BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT05625399: collaborators added: Halozyme Therapeutics.
Clinical trial NCT05625399: collaborators added: Halozyme Therapeutics.
Clinical trial NCT07547436: start date: 2026-05-04 → 2026-06-15.
Clinical trial NCT07454798: start date: 2026-05-01 → 2026-05-13.
Clinical trial NCT07605962 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-25 → 2026-05-20
Clinical trial NCT03958383 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-08-15 → 2025-12-09
Clinical trial NCT02519348: completion date: 2026-04-01 → 2026-12-18.
Clinical trial NCT05703971: primary completion date: 2026-02-01 → 2026-06-01.
Dormant shares - change in the number of shares
Globaltech Corp. (OTCQB: GLTK) Update to Shareholders
FORM 4-Tepper Oren